Chittasupho C.; Tadtong S.; Vorarat S.; Imaram W.; Athikomkulchai S.; Samee W.; Sareedenchai V.; Thongnopkoon T.; Okonogi S.; Kamkaen N.
(MDPI, 2022)
The first line therapy of patients with Parkinson’s disease, a neurodegenerative disorder caused by the degeneration of dopaminergic neurons, is levodopa (L-dopa) given orally. Recently, the presence of natural L-dopa in ...